China buys three U.S. soybean cargoes ahead of Trump-Xi meeting, Reuters reports

China buys three U.S. soybean cargoes ahead of Trump-Xi meeting, Reuters reports


China’s state-owned COFCO bought three U.S. soybean cargoes this week, two trade sources said.

Bloomberg | Bloomberg | Getty Images

China’s state-owned COFCO bought three U.S. soybean cargoes this week, two trade sources said, the country’s first purchases from this year’s U.S. harvest ahead of this week’s summit of leaders Donald Trump and Xi Jinping.

COFCO purchased about 180,000 metric tons of soybeans for December and January shipment through Pacific Northwest port terminals, the sources said.

COFCO did not immediately respond to a Reuters request for comment.

Benchmark Chicago soybean futures prices jumped this week to their highest in 15 months, rebounding from recent five-year lows on hopes for a U.S.-China trade deal.

China, the world’s biggest soy importer, shunned soybeans from the autumn U.S. harvest, switching its demand to South American suppliers amid trade conflict with Washington.

The unusual delay has already cost U.S. farmers billions of dollars in lost sales, after they largely supported Trump in his campaigns for president.



Source

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World
World

Why XRP ETFs are seeing steady inflows despite crypto’s pullback: CNBC Crypto World

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email On today’s episode of CNBC Crypto World, bitcoin falls as Wall Street rethinks some AI investments. Also, CF Benchmarks CEO Sui Chung discusses recent trends in crypto ETFs. Source

Read More
The chart that has Michael Burry worried about the stock market
World

The chart that has Michael Burry worried about the stock market

Michael Burry is warning that a shift in household wealth could leave the stock market vulnerable to a long and significant downturn. “The Big Short” investor pointed to a graphic produced by Wells Fargo showing that U.S. households now hold a larger share of their net worth in equities than in real estate — a […]

Read More
This biotech name is evolving into a major obesity play. How to trade it with options
World

This biotech name is evolving into a major obesity play. How to trade it with options

Amgen is entering a pivotal period the as it moves beyond its Enbrel franchise and repositions around obesity, rare disease and next-generation oncology. While Enbrel has entered a period of decline due to Medicare pricing reform, management has demonstrated credible execution in replacing that cash flow with a higher-quality pipeline. Early success from the Imdelltra […]

Read More